Clinical Trial Update: Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial compares intravitreal versus subcutaneous adalimumab for non-infectious uveitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Uveitis
• Uveitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Uveitis, Non-Infectious Uveitis | Phase 2 | Status: RECRUITING